Narlaprevir

Overview

Narlaprevir (SCH 900518) is a selective and orally bioavailable NS3 protease inhibitor with a K i value of 6 nM and an EC 90 value of 40 nM. Narlaprevir also inhibits the HCV nonstructural protein 3 serine protease . Narlaprevir is also a SARS-CoV 3CL pro inhibitor with an IC 50 of 2.3 μM.

Application

Products | Products > Disease Areas > Viral Infection | Products > Disease Areas > SARS-CoV-2 Infection | Products > Disease Areas > Hepatitis C Virus Infection | Products > Disease Areas > Infection | Products > Disease Areas > Coronavirus Infection | Products > Disease Areas > Hepatitis Virus Infection | Products > Signaling Pathways > Anti-infection | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Infection | Products > Signaling Pathways > HCV | Products > Signaling Pathways > HCV Protease | Products > Signaling Pathways > SARS-CoV

Product Information

• Catalog No.: HY-10300
• CAS No.: 865466-24-6
• Molecular Formula: C36H61N5O7S
• Molecular Weight: 707.96
• Purity: 95.88%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: ≥ 2.5 mg/mL (3.53 mM); Clear solution
• Availability: In-stock

Source

Original product source